BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6266683)

  • 1. The use of four-drug combination chemotherapy (D.A.V.E.) in the treatment of advanced Wilms' tumour.
    Dunger DB; Malpas JS; Graham-Pole JR; Sandland MR; Stansfeld AG; Freeman JE
    Cancer Chemother Pharmacol; 1981; 5(4):211-5. PubMed ID: 6266683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
    Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N;
    Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Beckwith JB; Breslow NE; Faria P; Moksness J; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S
    J Clin Oncol; 1994 Oct; 12(10):2126-31. PubMed ID: 7931483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilms' tumour: adjuvant treatment with actinomycin D and vincristine.
    Jenkin RD; Jeffs RD; Stephens CA; Sonley MJ
    Can Med Assoc J; 1976 Jul; 115(2):136-40. PubMed ID: 179690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Chemotherapy in Wilms' tumor. An appraisal.
    Sutow WW
    Cancer; 1973 Nov; 32(5):1150-3. PubMed ID: 4357073
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of chemotherapy in the treatment of Wilms' tumor in children].
    Bozek J; CzerwiƄski W; Kozera M; Ordyniec J; Perek D; Wozniak W; Taube K
    Probl Med Wieku Rozwoj; 1982; 11():237-42. PubMed ID: 6294649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ
    J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
    Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
    Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of Wilms' tumour management in two tertiary-care hospitals in Asia.
    Sen S; Kadamba P; Al-AbdulAaly M; Mammen KE; Ahmed S
    Pediatr Surg Int; 1998 Jan; 13(1):42-4. PubMed ID: 9391203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Green DM; Breslow NE; Evans I; Moksness J; D'Angio GJ
    Med Pediatr Oncol; 1996 Mar; 26(3):147-52. PubMed ID: 8544795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Wilms' tumor in childhood].
    Goldschmidt H; Bachmann KD
    Dtsch Med Wochenschr; 1974 Feb; 99(8):360-3. PubMed ID: 4362671
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy in the treatment of Wilms' tumor.
    Hawtrey CE
    J Iowa Med Soc; 1971 Jun; 51(6):356-7. PubMed ID: 4326115
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of Wilms' tumor with particular emphasis on combination treatment with radiation, actinomycin D and vincristine.
    Harrison J; Myers M; Wiley A; Vermund H
    Int J Radiat Oncol Biol Phys; 1976; 1(3-4):227-34. PubMed ID: 184070
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.
    Green DM; Cotton CA; Malogolowkin M; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D
    Pediatr Blood Cancer; 2007 May; 48(5):493-9. PubMed ID: 16547940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of intra-abdominal relapse (IAR) in patients with Wilms' tumor who received radiation: analysis by histopathology. A report of National Wilms' Tumor Studies 1 and 2 (NWTS-1 & 2).
    Tefft M; D'Angio GJ; Beckwith B; Farewell V; Meyer JA
    Int J Radiat Oncol Biol Phys; 1980 Jun; 6(6):663-7. PubMed ID: 6256318
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S; Haase G; Ritchey M; Kelalis P; D'Angio GJ
    J Clin Oncol; 1998 Dec; 16(12):3744-51. PubMed ID: 9850017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study.
    D'Angio GJ; Evans A; Breslow N; Beckwith B; Bishop H; Farewell V; Goodwin W; Leape L; Palmer N; Sinks L; Sutow W; Tefft M; Wolff J
    Cancer; 1981 May; 47(9):2302-11. PubMed ID: 6164480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Wilms' tumour. Current recommendations.
    Mehta MP; Bastin KT; Wiersma SR
    Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilms' tumor in an adult patient.
    Palou J; Banus JM; Bellmunt J; Carulla J; Egido R
    Urol Int; 1988; 43(6):349-51. PubMed ID: 2467422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.
    Pritchard-Jones K; Kelsey A; Vujanic G; Imeson J; Hutton C; Mitchell C; ;
    J Clin Oncol; 2003 Sep; 21(17):3269-75. PubMed ID: 12947062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.